Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)

Name: Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)
Published: 2020
License: Public Domain

Laboratorios Roemmers S.A.I.C.F. · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

coronavirus-infections respiratory-tract-infections

covid-19, nitazoxanide, coronavirus infections, rna virus infections, respiratory tract infections, virus diseases, respiratory tract diseases, antiparasitic agents, interventional, phase2, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)

Related documents